Matti Narkia's Library tagged → View Popular
Fatty acid intake and the risk of community-acquired pneumonia in US women
Fatty acid intake and the risk of community-acquired pneumonia in U.S. women.
Alperovich M, Neuman MI, Willett WC, Curhan GC.
Nutrition. 2007 Mar;23(3):196-202. Epub 2007 Jan 22.
PMID: 17236748
doi: 10.1016/j.nut.2006.11.007.
Conclusions
Fatty acid intake may affect the risk of community-acquired pneumonia in young and middle-aged women. Higher dietary intake of palmitic acid and possibly DHA and EPA may increase the risk of community-acquired pneumonia in women while higher oleic acid intake may decrease the risk.
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes - Ann Intern Med
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial.
Esposito K, Maiorino MI, Ciotola M, Di Palo C, Scognamiglio P, Gicchino M, Petrizzo M, Saccomanno F, Beneduce F, Ceriello A, Giugliano D.
Ann Intern Med. 2009 Sep 1;151(5):306-14. Erratum in: Ann Intern Med. 2009 Oct 20;151(8):591.
PMID: 19721018
Conclusion: Compared with a low-fat diet, a low-carbohydrate, Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy in overweight patients with newly diagnosed type 2 diabetes.
One-Year Comparison of a High-Monounsaturated Fat Diet With a High-Carbohydrate Diet in Type 2 Diabetes - Diabetes Care
One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes.
Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D'Alessio DA.
Diabetes Care. 2009 Feb;32(2):215-20. Epub 2008 Oct 28.
PMID: 18957534
doi: 10.2337/dc08-0687
CONCLUSIONS—In individuals with type 2 diabetes, high-MUFA diets are an alternative to conventional lower-fat, high-CHO diets with comparable beneficial effects on body weight, body composition, cardiovascular risk factors, and glycemic control.
Vitamin D Deficiency and Risk of Cardiovascular Disease -- Wang et al. 117 (4): 503 -- Circulation
Vitamin D deficiency and risk of cardiovascular disease.
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS.
Circulation. 2008 Jan 29;117(4):503-11. Epub 2008 Jan 7.
PMID: 18180395
doi: 10.1161/CIRCULATIONAHA.107.706127
Conclusions— Vitamin D deficiency is associated with incident cardiovascular disease. Further clinical and experimental studies may be warranted to determine whether correction of vitamin D deficiency could contribute to the prevention of cardiovascular disease.
Blood -- Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.
Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.
Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C.
Blood. 2007 Apr 1;109(7):2823-31.
PMID: 17138823
DOI 10.1182/blood-2006-07-035345.
This is the first study in rats demonstrating that AC and the resulting decreased arterial distensibility are reversible by high-VK intakenstrating that AC and the resulting decreased arterial distensibility are reversible by high-VK intake
Vitamin D Deficiency and Risk of Cardiovascular Disease -- Wang et al., 10.1161/CIRCULATIONAHA.107.706127 -- Circulation (free full text PDF available)
Vitamin D deficiency and risk of cardiovascular disease.
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS.
Circulation. 2008 Jan 29;117(4):503-11. Epub 2008 Jan 7.
PMID: 18180395
doi: 10.1161/CIRCULATIONAHA.107.706127
Conclusions—Vitamin D deficiency is associated with incident cardiovascular disease. Further clinical and experimental studies may be warranted to determine whether correction of vitamin D deficiency could contribute to the prevention of cardiovascular disease.
High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. - Mary Ann Liebert, Inc. - Breastfeeding Medicine - 1(2):59
High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study.
Wagner CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW.
Breastfeed Med. 2006 Summer;1(2):59-70.
PMID: 17661565
doi:10.1089/bfm.2006.1.59.
Objective: To examine the effect of high-dose maternal vitamin D3 (vitD) supplementation on the nutritional vitD status of breastfeeding (BF) women and their infants compared with maternal and infant controls receiving 400 and 300 IU vitD/day, respectively.
Design: Fully lactating women (n = 19) were enrolled at 1–month postpartum into a randomized- control pilot trial. Each mother received one of two treatments for a 6–month study period: 0 or 6000 IU vitD3 plus a prenatal vitamin containing 400 IU vitD3. The infants of mothers assigned to the control group received 300 IU vitD3/day; those infants of mothers in the high-dose group received 0 IU (placebo). Maternal serum and milk vitD and 25(OH)D were measured at baseline then monthly; infant serum vitD and 25(OH)D were measured at baseline, and months 4 and 7. Urinary calcium/creatinine ratios were measured monthly in both mothers and infants. Dietary and BF history and outdoor activity questionnaires were completed at each visit. Changes in skin pigmentation were measured by spectrophotometry. Data were analyzed using chi-square, t-test, and analysis of variance (ANOVA) on an intent-to-treat basis.
Conclusion: With limited sun exposure, an intake of 400 IU/day vitamin D3 did not sustain circulating maternal 25(OH)D levels, and thus, supplied only extremely limited amounts of vitamin D to the nursing infant via breast milk. Infant levels achieved exclusively through maternal supplementation were equivalent to levels in infants who received oral vitamin D supplementation. Thus, a maternal intake of 6400 IU/day vitamin D elevated circulating 25(OH)D in both mother and nursing infant.
The Polyp Prevention Trial-Continued Follow-up Study: No Effect of a Low-Fat, High-Fiber, High-Fruit, and -Vegetable Diet on Adenoma Recurrence Eight Years after Randomization - Cancer Epidemiology, Biomarkers & Prevention
The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E, Yu B, Murphy G, Albert PS, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery M, Burt R, Iber F, Shike M, Kikendall JW, Brewer BK, Schatzkin A; Polyp Prevention Trial Study Group.
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1745-52.
PubMed PMID: 17855692
doi: 10.1158/1055-9965.EPI-07-0127
his study failed to show any effect of a low-fat, high-fiber, high-fruit and -vegetable eating pattern on adenoma recurrence even with 8 years of follow-up.
Dietary protein and bone health: a systematic review and meta-analysis -- Darling et al. 90 (6): 1674 -- American Journal of Clinical Nutrition
Dietary protein and bone health: a systematic review and meta-analysis.
Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA.
Am J Clin Nutr. 2009 Nov 4. [Epub ahead of print]
PMID: 19889822
Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: The Genetics of Coronary Artery Disease in Alaska Natives study - ScienceDirect - Atherosclerosis
Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Coronary Artery Disease in Alaska Natives study.
Ebbesson SO, Roman MJ, Devereux RB, Kaufman D, Fabsitz RR, Maccluer JW, Dyke B, Laston S, Wenger CR, Comuzzie AG, Romenesko T, Ebbesson LO, Nobmann ED, Howard BV.
Atherosclerosis. 2008 Aug;199(2):346-53. Epub 2007 Dec 4.
PMID: 18054937
doi:10.1016/j.atherosclerosis.2007.10.020
Conclusions
Dietary intake of omega-3 FAs in a moderate-to-high range does not appear to be associated with reduced plaque, but is negatively associated with IMT. The presence and extent of carotid atherosclerosis among Eskimos is higher with increasing consumption of saturated FAs.
Prevalence and Correlates of Subclinical Atherosclerosis in Alaska Eskimos: The GOCADAN Study -- Cutchins et al. 39 (11): 3079 -- Stroke
Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study.
Cutchins A, Roman MJ, Devereux RB, Ebbesson SO, Umans JG, Zhu J, Weissman NJ, Howard BV.
Stroke. 2008 Nov;39(11):3079-82. Epub 2008 Jul 10.
PMID: 18617652
doi: 10.1161/STROKEAHA.108.519199
Conclusions— Alaska Eskimos have similar traditional risk factors for carotid atherosclerosis as other ethnic and racial populations but have higher prevalences of atherosclerosis, possibly attributable to higher rates of smoking.
Intima-media thickness of the carotid artery and the distribution of lipoprotein subclasses in men aged 40-49 between whites in the U.S. and the Japanese in Japan for the ERA JUMP Study
Intima-media thickness of the carotid artery and the distribution of lipoprotein subclasses in men aged 40 to 49 years between whites in the United States and the Japanese in Japan for the ERA JUMP study.
Sekikawa A, Ueshima H, Sutton-Tyrrell K, Kadowaki T, El-Saed A, Okamura T, Takamiya T, Ueno Y, Evans RW, Nakamura Y, Edmundowicz D, Kashiwagi A, Maegawa H, Kuller LH.
Metabolism. 2008 Feb;57(2):177-82.
PMID: 18191046
doi: 10.1016/j.metabol.2007.08.022.
In men in the post World War II birth cohort, i.e., men aged 40–49, whites in the United States (U.S.) had significantly higher levels of intima-media thickness of the carotid arteries (IMT) than the Japanese in Japan.
The whites had significantly higher levels of large very-low-density-lipoprotein particles and significantly lower levels of large high-density-lipoprotein particles than the Japanese, whereas the two populations had similar levels of small low-density-lipoprotein particles. The two populations had similar associations of IMT with NMR lipoproteins. Adjusting for NMR lipoproteins did not attenuate the significant difference in IMT between the two populations (0.671 ± 0.006 for the whites and 0.618 ± 0.006 mm for the Japanese, P=0.01, mean (standard error)). Differences in the distributions of NMR lipoproteins between the two populations did not explain the higher IMT in the whites.
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese Americans, and Whites: a cross-sectional study
Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study.
Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, Evans RW, Rodriguez BL, Okamura T, Sutton-Tyrrell K, Nakamura Y, Masaki K, Edmundowicz D, Kashiwagi A, Willcox BJ, Takamiya T, Mitsunami K, Seto TB, Murata K, White RL, Kuller LH; ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group.
J Am Coll Cardiol. 2008 Aug 5;52(6):417-24.
PMID: 18672160
Conclusions
Very high levels of marine-derived n-3 FAs have anti-atherogenic properties independent of traditional cardiovascular risk factors and may contribute to lower burden of atherosclerosis in Japanese in Japan, which is unlikely due to genetic factors.
Safety of vitamin D3 in adults with multiple sclerosis -- Kimball et al. 86 (3): 645 -- American Journal of Clinical Nutrition
Safety of vitamin D3 in adults with multiple sclerosis.
Kimball SM, Ursell MR, O'Connor P, Vieth R.
Am J Clin Nutr. 2007 Sep;86(3):645-51.
PMID: 17823429
Conclusions: Patients' serum 25(OH)D concentrations reached twice the top of the physiologic range without eliciting hypercalcemia or hypercalciuria. The data support the feasibility of pharmacologic doses of vitamin D3 for clinical research, and they provide objective evidence that vitamin D intake beyond the current upper limit is safe by a large margin.
DIRECT-MS
"In 1995 my son received the devastating diagnosis of MS. Having been a research scientist for 30 years, I decided to plunge into the scientific literature for MS to determine the most likely factors which cause MS and to use this information to develop an effective therapy for my son.
Notably, many people are having great success in halting or greatly slowing MS with nutritional strategies; many Testimonials are available. I am most pleased to report that my son remains in excellent health with no MS symptoms.
I discovered abundant scientific evidence that indicates that various nutritional factors potentially play major roles in the onset and progression of MS. Strangely, this information was not being made available to persons with MS by doctors nor by established MS charities."
Vitamin D and MS: Vieth
Professor Departments of Nutritional Sciences, Laboratory Medicine, and Pathobiology, Bone and Mineral Laboratory, Pathology and Laboratory Medicine,
University of Toronto, Toronto, Canada M5S 3E2
Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada
Vitamin D and MS
"This website is about Vitamin D and MS
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS), with an uncertain cause. Colleen Hayes and Donald Achaeson have suggested that insufficient sunlight exposure and chronic viral infections might be unrelated environmental risk factors for MS. These risk factors may act synergistically to enable the pathogenic autoimmune response.
The prevalence of MS is highest where environmental supplies of vitamin D are lowest. Sunshine enables the production of vitamin D3 (VD3) in the skin. Epidemiological studies have shown that higher vitamin D blood levels are associated with lower risk, less relapses and a slower progression of multiple sclerosis. Higher vitamin D levels can be achieved in part by increased oral intake of VD3.
Optimal health requires serum 25 hydroxyvitamin D levels higher than 20 ng/ml (50 nmol/L) P Lips, 40 ng/ml (100 nmol/L) P Heaney or at least 40 ng/ml (100 nmol/L) R Vieth. "
JAMA -- Abstract: Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12, November 18, 2009, Ebbing et al. 302 (19): 2119
Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12.
Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Refsum H, Nilsen DW, Tverdal A, Meyer K, Vollset SE.
JAMA. 2009 Nov 18;302(19):2119-2126. v
PMID: 19920236
Conclusion Treatment with folic acid plus vitamin B12 was associated with increased cancer outcomes and all-cause mortality in patients with ischemic heart disease in Norway, where there is no folic acid fortification of foods.
Can lifestyle changes reverse coronary heart disease? : The Lancet
Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.
Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL.
Lancet. 1990 Jul 21;336(8708):129-33.
PMID: 1973470
The carnivore connection: dietary carbohydrate in the evolution of NIDDM. - [Diabetologia. 1994] - PubMed result
The carnivore connection: dietary carbohydrate in the evolution of NIDDM.
Miller JC, Colagiuri S.
Diabetologia. 1994 Dec;37(12):1280-6.
PMID: 7895958
Selected Tags
Related Tags
Sponsored Links
Top Contributors
Groups interested in research
-
Online identity research
Collection of resources for...
Items: 276 | Visits: 2313
Created by: Adam Bohannon
-
Biology
focus on science of living ...
Items: 63 | Visits: 1892
Created by: Sheryl A. McCoy
-
web 2.0 research
A collection of resources f...
Items: 31 | Visits: 2493
Created by: Mark Marino
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo
